Tuberculosis (TB) is an infectious disease and, apart from protecting patients, attention must be given to protecting the persons who come in contact with them, especially nurses and medical practitioners. A 43-yearold immunocompetent male nurse developed occupationally disseminated TB after contact with patients affected by active TB (culture positive) while working in a psychiatric hospital. The first manifestation of the disease was exudative pericarditis with Mycobacterium tuberculosis (MT) confirmed two months after pericardiocentesis and evacuation of 1200 mL of pericardial effusion. Many lymph nodes showed histologic findings of granulomatous inflammation with necrosis. Treatment with antituberculosis drugs caused complications, including transient short-term medication-induced toxic hepatitis, prolonged fever, left pleural nonspecific effusion, and mononeuritis of the right peroneus nerve. The treatment lasted 14 months and led to permanent consequences, including fibrothorax with restrictive ventilation disorders and reduced diffusion of the alveolar-capillary membrane. This case highlights the need to improve the protection of health care workers who are in contact with TB patients, as well as the usefulness of the tuberculin skin test and QuantiFERON-TB test, which can be used to identify early latent TB. Flego V, et al. OCCUPATIONAL TUBERCULOSIS IN A HEALTH CARE WORKER Arh Hig Rada Toksikol 2014;65:417-422 The incidence of active tuberculosis (TB) among health care workers (HCW) has been reported to be 0.4 % in Germany, 1.0 % in Portugal, or up to 2.5 % in Brazil (1-3), with nurses enduring the highest risk, followed by physicians. Nurses are at a greater risk of acquiring TB if they work in pulmonary medicine or human immunodeficiency virus (HIV) wards, likely due to repeated contact with infected patients (4). The risk of developing TB is highest during the first years of exposure. The predominant clinical presentations are extrapulmonary cases (48 %), followed by pulmonary (44 %) and combination cases (8 %) (5). The most common forms of extrapulmonary TB (EPTB) include pleural, lymph node, osteoarticular, and abdominal TB. Other localisations such as central nervous system, urogenital, breast, chest wall, cutaneous, middle ear, and pericardial TB are rarely observed (6, 7). Pericarditis is a rare manifestation of TB, occurring in approximately 1-2 % of all TB cases (8). TB accounts for up to 4 % of acute pericarditis and 7 % of cardiac tamponade (5). Organisms usually spread to the pericardium from the mediastinal or hilar lymph nodes or from the lungs, and rarely as part of miliary TB. Tuberculous pericarditis (TBP) is a potentially lethal condition, and its prompt treatment can be lifesaving. Effective treatment requires a rapid and accurate diagnosis, which is often difficult. In occupationally exposed staff, pericardial effusion non-responsive to routine therapy should arouse suspicion of occupational TBP.
The incidence of active tuberculosis (TB) among health care workers (HCW) has been reported to be 0.4 % in Germany, 1.0 % in Portugal, or up to 2.5 % in Brazil (1) (2) (3) , with nurses enduring the highest risk, followed by physicians. Nurses are at a greater risk of acquiring TB if they work in pulmonary medicine or human immunodeficiency virus (HIV) wards, likely due to repeated contact with infected patients (4) . The risk of developing TB is highest during the first years of exposure. The predominant clinical presentations are extrapulmonary cases (48 %), followed by pulmonary (44 %) and combination cases (8 %) (5) . The most common forms of extrapulmonary TB (EPTB) include pleural, lymph node, osteoarticular, and abdominal TB. Other localisations such as central nervous system, urogenital, breast, chest wall, cutaneous, middle ear, and pericardial TB are rarely observed (6, 7) . Pericarditis is a rare manifestation of TB, occurring in approximately 1-2 % of all TB cases (8) . TB accounts for up to 4 % of acute pericarditis and 7 % of cardiac tamponade (5) . Organisms usually spread to the pericardium from the mediastinal or hilar lymph nodes or from the lungs, and rarely as part of miliary TB. Tuberculous pericarditis (TBP) is a potentially lethal condition, and its prompt treatment can be lifesaving. Effective treatment requires a rapid and accurate diagnosis, which is often difficult. In occupationally exposed staff, pericardial effusion non-responsive to routine therapy should arouse suspicion of occupational TBP.
Here, we report a case of TBP in a 43-year-old male nurse. Following a positive culture of Mycobacterium tuberculosis (MT) from the pericardial fluid, he immediately began undergoing treatment with antituberculous chemotherapy.
Case report and discussion
The 43-year-old male patient had been employed as a male nurse in a chronic psychiatric hospital for eight months before experiencing the first symptoms. He had received BCG vaccination and had a scar on his left upper arm. The patient had no history of tuberculosis, diabetes, or immunosuppression. He was not a smoker, did not drink alcohol or abuse drugs.
Four months before the onset of the first symptoms, our patient was in daily contact with five patients suffering from active pulmonary TB (nosocomial TB), as shown by a positive sputum culture for MT. The patient had a negative Mantoux test at the start of his employment, as well as four months later. After an additional three months, his Mantoux test was 22×25 mm, showing hyperresponsiveness. At the same time, his QUANTIFERON-TB test result was also positive (8.19 IU mL -1 ). Two weeks before these positive test results, he was subfebrile for ten days. Radiological findings of the thorax were normal. Sputum was sent for microbiological examination. Ziehl-Neelsen stained smears did not show acid-fast bacilli. Six weeks later, the patient presented a fever of 39.5 °C, pain in the epigastrium, and shortness of breath with effort. He was hospitalized at the Department for Infectious Diseases, where ultrasound findings established pericardial effusion. The patient was then transferred to the Department of Cardiovascular Diseases, where he underwent pericardiocentesis and evacuation of 1200 mL of pericardial effusion. The aetiology of pericardial effusion was not established, and the patient was treated with prednisone 40 mg at decreasing doses.
Two months later, at a prednisone dose of 5 mg, the patient once again became febrile. Pericardial effusion was still found and the prednisone dose was increased to 30 mg. The patient remained febrile and fatigued. The prolonged-incubation mycobacteria growth indicator tube (MGIT) showed positive findings in the sputum collected four months earlier.
Positive findings were also established in MGIT and cultures on Lowenstein-Jensen media of pericardial effusion samples from two months earlier. The patient was hospitalised at the Department of Pulmonology. Prednisone treatment was rapidly decreased and antituberculosis treatment was initiated with isoniazid 400 mg, rifampicin 600 mg, and ethambutol 1200 mg. Radiological findings of the thorax were normal. After a month of hospital treatment, the patient was discharged to his home, without a fever and in good general condition.
A week later, the patient was again admitted to the Department of Pulmonology with a temperature of 39.5 °C and pain in the left side of the chest. Extensive left pleural effusion was established (Figures 1 and  2 ). On two occasions, thoracocentesis was performed, removing 900 and 600 mL of pleural effusion-type exudate. Treatment with piperacillin/tazobactam 4.5 g i.v. every 8 hours was started, but the fever persisted. We performed two additional thoracocenteses, removing a total of 1500 mL of additional pleural effusion. Cytological findings of extracted pleural effusion included non-specific inflammation, and bacteriological examination revealed sterility. Treatment continued with antituberculosis drugs (isoniazid 400 mg, rifampicin 600 mg, ethambutol 1200 mg, pyrazinamide 1.5 g) and prednisone 25 mg. Pleural effusion gradually regressed, but the patient remained continuously febrile. After a month of treatment, the patient's fever subsided and prednisone treatment was suspended. A few days later, the patient's temperature rose to 38.5 °C and would not decrease for two weeks. Multislice computed tomography (MSCT) revealed lesions consistent with active pulmonary tuberculosis and enlarged lymph nodes (neck, axilla, mediastinum, and groin), a small left pleural effusion, and a small pericardial effusion. Treatment with antituberculosis drugs was further complicated by transient shortterm medication-induced toxic hepatitis, prolonged fever of unclear aetiology, pleural effusion of unclear aetiology, and mononeuritis of the right nervus peroneus. To make sure that no other condition was causing the fever (lymphoma), positron emission tomography-computed tomography (PET/CT) scanning was performed, showing a number of metabolically active lesions in the lymph nodes and the left pleura. The patient was further investigated by cytologic puncture of three nodes (axilla and groin), and biopsy of a lymph node in the right groin. The findings showed granulomatous inflammation with necrosis and further treatment was started with rifampicin 600 mg and isoniazid 400 mg.
Two months later, an echocardiogram showed no pericardial effusion, pulmonary hypertension, or constrictive pericarditis. Spirometry indicated restrictive ventilation disorders of an intermediate level, due to a higher left side fibrothorax. It was recommended that the patient continue taking rifampicin and isoniazid. Three months later at a check-up with the pulmonologist, the patient exhibited no fever and felt well, except for the occasional stabbing pain in the left part of the chest. Further treatment with rifampicin and isoniazid was recommended. Three months later, radiological examination showed residual pleuropulmonary changes, which was a consequence of tuberculous infection. Treatment with rifampicin and isoniazid continued. After 14 months, the antituberculosis treatment was completed. The patient still felt shortness of breath, intolerance of effort, and a constant stabbing pain in the left part of the chest. As a result of excessive tuberculosis, there were residual consequences in the form of a left fibrothorax, restrictive disorders of ventilation (FVC 53.1 %), and reduced diffusion of carbon monoxide (DLCO 48.5 %) ( Table 1 ). The patient is now employed at a location where he is no longer exposed to contact with MT and can avoid greater physical exertion.
This case is important for several reasons. TB is a rare disease in the general population, but is the most common occupational infectious disease among HCWs. Tuberculous pericarditis is an uncommon 
Figure 2 Axial computed tomography (CT) scan (left) and coronal reformatted CT image (right) of the chest showing left pleural effusion
localization of EPTB and is rarely the first manifestation of generalized TB. The presently reported patient became very ill soon after contact with patients suffering from active TB, but the MT culture of sputum on Lowenstein-Jensen media became positive only after four months. Finally, the patient suffered notable complications during treatment with antituberculosis drugs, and severe and permanent damage after TB was cured.
In 2009, Croatia reached the levels of other European countries with low incidence of TB, reaching a notification rate of below 20 TB cases per 100,000 inhabitants for the first time. The rate of occupational diseases among those working in health care and social care in Croatia was 11.78/100,000 employees (9) . Occupational diseases were reported in 3 % of Croatian HCWs between 2002 and 2009, with infectious diseases comprising 68 % of such cases (10). Among these occupational infectious diseases in HCWs, 27 % were TB (the most common). According to these data, the incidence of active TB as an occupational disease in HCWs in Croatia is 0.6 %. Among occupational diseases in HCWs, 39 % occurred in nurses and 23 % in doctors. There is mounting evidence that HCWs are at an increased risk of contracting a TB infection and developing the disease (11) . Effective environmental and personal protective measures, along with education of patients and HCW are urgently needed to reduce the occupational risk of TB.
EPTB occurs in 15-20 % of immunocompetent and 20-70 % of HIV-infected patients with TB (12) . Studies from the Netherlands and the US show that EPTB is more often diagnosed in women and is associated with ethnic minorities and those born in other countries (13) . Tuberculous pericarditis is seen in 1-8 % of EPTB patients (14) . A stratification of the data by high-and low-incidence countries shows a higher proportion of EPTB in low-incidence countries. The proportion of EPTB increased during the period from 2002 to 2011 in the European Union, mainly because the notification rate of pulmonary TB decreased (15) . TB is diagnosed in only 4 % of acute pericarditis cases (16) , while pericarditis may be seen in 1-2 % of pulmonary tuberculosis cases. It is difficult to isolate Mycobacterium species from pericardial fluid samples and only one-third of such samples are diagnostic.
The presently reported patient had generalised TB with lymph nodes, pericardium, and coexisting pulmonary TB. TBP was the first evidence of generalized TB, which is very rare (17) . The significant amount of time it took to diagnose the patient contributed to the severe clinical disease condition and long duration of treatment. The disease was recognized as occupational and our patient was no longer capable of performing the work he performed before contracting the disease. It is favourable that this patient did not develop constrictive pericarditis, which is often a severe and permanent consequence of TBP (18, 19) .
Tuberculous pericardial effusion rarely occurs in immunocompetent persons. Our present case demonstrates the need for a higher index of suspicion for TB in any case of pericardial effusion, particularly among HCWs with previous exposure to TB. Assessment of TB as an occupational disease should be limited to occupationally exposed populations. Tuberculin skin test and QUANTIFERON-TB tests can identify early latent TB and are useful for 
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diagnosing contact with MT in low-incidence countries, even in a vaccinated population, as well as for directing diagnoses to active TB (20) .
